EAU Podcasts

In this episode, Dr. Hanny Cobussen-Boekhorst, a nurse practitioner (NP) and a member of the EAU guidelines panel for Female Lower Urinary Tract Symptoms (LUTS), discusses her motivation and contribution to the guidelines panel. Multidisciplinary collaboration is the future, and as a nurse, Dr. Cobussen-Boekhorst talks about the benefits of having a nurse-specialist involved in female LUTS managem...

In this podcast, Prof. Bhaskar Somani (GB), an associate of the EULIS - Working Group on ureteroscopic management of stones, and Mr. Patrick Jones (NO), a member of the EAU Young Academic Urology urolithiasis group, discuss the challenges of urolithiasis in pregnancy. The management of kidney stones during pregnancy can be challenging for most urologists in terms of using the right diagnostics and...

Dr. Felix Campos-Juanatey (ES), a member of the EAU Guidelines Panel for Urethral Strictures, answers questions on the diagnosis of urethral strictures and follow-up after urethral surgery.   This podcast begins with details on what patient information is necessary to collect during an in-depth clinical interview and examination to make an accurate diagnosis.  Dr. Campos-Juanatey shares the latest...

In this edition, Dr.  Margarida Manso (PT), associate member of the EAU Section of Female and Functional Urology (ESFFU), discusses female stress urinary incontinence (SUI).  Dr. Manso details the physiological elements of SUI in regards to the bladder neck and urethra, as well as the urinary sphincter.  The multiple causes behind SUI are outlined, including: ageing, radiotherapy trauma and neurol...

In this edition, Dr. Lazaros Tzelves (GR), a member of the EAU Guidelines Panel for non-neurogenic female LUTS, discusses underactive bladder (UAB) in women.  Dr. Tzelves clinically defines what an underactive bladder is, followed by sharing information on its prevalence and aetiology.  UAB is difficult to diagnose and difficult to manage. Dr Tzelves discusses how urologists can diagnostically app...

In this podcast, EAU Prostate Cancer Guidelines Panel members Prof. Nicolas Mottet (FR) and Prof. Philip Cornford (GB), have an in-depth discussion on active surveillance in prostate cancer.  The two experts elaborate in detail on what active surveillance is, including the difference between active surveillance and watchful waiting, which can often be mis-understood.  Prof. Mottet and Prof. Cornfo...

In this edition, we have Dr. Maria Carmen Mir (ES), chief editor of the UROONCO RCC editorial board, together with Prof. Alessandro Antonelli (IT) from the University of Verona and director of the Department of Urology at Borgo Trento Hospital, talking about the retroperitoneal approach to robotic partial nephrectomy (RPN). Prof. Antonelli begins this interview with a review on transrectal and tra...

In this edition, we have Dr. Riccardo Bertolo (IT), the associate editor of UROONCO RCC editorial board, together with Dr. Alberto Breda (ES), Head of the Oncology Urology Unit and Kidney Transplant Surgical Team Urology Department, Fundació Puigvert, Barcelona, and chairman of ERUS and president of the ERUS22 congress, talking about the novel alternative robotic platform that was recently launche...

In this edition, Dr. Constance Thibault (FR), associate editor of the UROONCO PCa educational platform, discusses triplet therapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).  In the last decade, the outcome of metastatic prostate cancer has been improved by intensifying the systemic therapy with the addition of docetaxel and/or new hormonal therapies. Clinicians now...

During this episode, Dr. Thomas Seisen (FR), an associate member on the EAU Guidelines Panel for Non-Muscle Invasive Bladder Cancer,  answers questions about metastatic upper urothelial cancer (UTUC) treatment options in the 2022 guidelines: What are the systemic treatment options for metastatic UTUC in the first-line setting? Can a maintenance systemic treatment be proposed to metastatic UTUC pat...

In this edition, we have Dr. Teele Kuusk (UK), the associate editor of the UROONCO RCC educational platform discussing kidney cancer highlights at the recent ESMO2022. Dr. Kuusk begins with the reporting of several new trials and the accompanying results, which include: Phase 3 CheckMate-914, Phase 3 COSMIC-313, Phase 2 Keynote-B61, and Cohort 1 of LITESPARK-003 study. After delivering the trial r...

In this podcast, members of the EAU Guidelines Panel for RCC Prof. Axel Bex (DE)  and Prof. Jens Bedke (DE), discuss renal cell carcinoma (RCC), with updates on treatments and current trials.  Prof. Bex and Prof. Bedke talk about what's new in adjuvant treatment for patients with high-risk RCC after radical nephrectomy.  This follows with discussions on the combination and triplet trials, as...

In this edition we have Dr. Benoît Peyronnet (FR), a Panel Member, and Dr. Néha Sihra (UK), an associate member of the EAU Guidelines Panel for female lower urinary tract symptoms, discussing overactive bladder syndrome (OAB) in women.  Ms. Sihra answers questions about what to do when evaluating an overactive bladder patient. She covers the importance of clinical history, and which type of examin...

In this podcast, EAU Guidelines office member, Prof. Philip Cornford (GB), and Prostate Cancer Panel patient representative, Dr. Erik Briers (BE),  share their views on the importance of patient input in authoring the EAU Guidelines. Our discussants review the relationship between specialists and their patients, and how they can create better advocacy, as well as, increased involvement going forwa...

In this edition, Prof. Christian Radmayr talks about the importance of the dissemination of the EAU Guidelines.  Prof. Christian Radmayr is a member of the Paediatric Urology Guidelines Panel and chair of this panel since 2018. In this episode he touches on the various platforms through which the EAU Guidelines are disseminated, which initatives have the most impact and how clear communication of...

In this podcast, Prof. Peter Gilling (NZ), Professor of Surgery at the University of Auckland, shares details with us on the main findings of the WATER study.  Prof. Gilling gives us some insights into the five-year results of the WATER study, a pivotal trial that compares Aquablation versus transurethral resection of the prostate (TURP). The results were presented at the 2022 EAU Annual Congress....

In this edition, we have Prof. Tamsin Greenwell (GB), a panel member on the EAU Guidelines Panel for Urethral Strictures, discussing the management of female urethral stricture disease.  Prof. Greenwell begins with an overview on the causes of female urethral strictures and how a diagnosis should be made. Following this she answers questions on treatment options, including what type of urethroplas...

In this podcast, Dr. Vasileios Sakalis (GR), a member of the EAU Guidelines Panel for Male Lower Urinary Tract Symptoms, reports on the new section in the guidelines relating to Male Urinary Incontinence. Dr Vasileios Sakalis begins with information on an important addendum to the 2022 Male LUTS Guidelines with regard to the new incontinence section, and the reasons why this new section has been i...

In this commentary, Assoc. Prof. Fardod O'Kelly (IE), member of the EAU Guidelines Panel for paediatric urology, shares his expert knowledge on nocturnal enuresis, also known as bedwetting. Assoc. Prof. O'Kelly begins by answering questions on the prevalence of bedwetting among children, teenagers and into adulthood. More details are given to define this heritable condition, as well as c...

Professors Giulio Del Popolo and Gilles Karsenty (panel members), are joined by Dr. Stefania Musco (associate member) of the EAU Guidelines Panel for Neuro-urology, to talk about N-SUI. In this commentary three experts share their knowledge of neurogenic stress urinary incontinence (N-SUI); from surgical management, urodynamic evaluation, bulking agents, and other treatments, including artificial...

Dr. Sajjad Rahnama'i (NL), a member of the EAU Section of Female & Functional Urology, will discuss neurogenic detrusor overactivity, including its diagnosis and treatment. Several questions will be answered. What is neurogenic detrusor overactivity, and can it be a serious condition? What is the standard diagnostic workup of a patient in whom we suspect neurogenic detrusor overactivity?...

Dr. Richard Cathomas, medical oncologist from Zurich in Switzerland discusses Immunotherapy in muscle-invasive bladder cancer. He goes into the mechanism of action of immunotherapy and why could it work well in bladder cancer.  Where do we currently stand with the use of immunotherapy in the NEOADJUVANT setting of muscle invasive bladder cancer? And what is currently the best place to integrate im...

In this second edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, discusses which are the most important changes and new recommendations in the new EAU Guidelines for prostate cancer for 2022 relating to treatment approaches.

In this first edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, highlights the work of the panel. His talk includes new systematic reviews, and outlines which are the most important changes in the new EAU Guidelines for prostate cancer for 2022 relating to the definition of clinically localized and clinically significant prostate cancer, d...

What exactly is pain? What do I have to know about pain if I am treating patients with chronic pelvic pain? What is necessary to diagnose a chronic pelvic pain syndrome? What factors are key to successfully treat patients with a chronic pelvic pain syndrome? And what are the psychological aspects of chronic pain? Prof Daniel Engeler answers these questions. Prof Engeler is chairman of the EAU Guid...